These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 84030)

  • 1. Immunogenicity of liposomal model membranes sensitized with dinitrophenylated phosphatidylethanolamine derivatives containing different length spacers.
    Dancey GF; Isakson PC; Kinsky SC
    J Immunol; 1979 Feb; 122(2):638-42. PubMed ID: 84030
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of liposomal model membrane immunogenicity by incorporation of lipid A.
    Dancey GF; Yasuda T; Kinsky SC
    J Immunol; 1977 Dec; 119(6):1868-73. PubMed ID: 334974
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of liposomal model membrane composition on immunogenicity.
    Dancey GF; Yasuda T; Kinsky SC
    J Immunol; 1978 Apr; 120(4):1109-13. PubMed ID: 641340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative immunogenic properties of N-substituted phosphatidylethanolamine derivatives and liposomal model membranes.
    Nicolotti RA; Kochibe N; Kinsky SC
    J Immunol; 1976 Nov; 117(5 Pt.2):1898-902. PubMed ID: 62794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of liposomal model membranes.
    Kinsky SC
    Ann N Y Acad Sci; 1978; 308():111-23. PubMed ID: 279284
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement of immunogenicity by incorporation of lipid A into liposomal model membranes and its application to membrane-associated antigens.
    Tamauchi H; Tadakuma T; Yasuda T; Tsumita T; Saito K
    Immunology; 1983 Dec; 50(4):605-12. PubMed ID: 6360851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: Immunogenicity of liposomal model membranes sensitized with N-substituted phosphatidylethanolamine derivatives.
    Kinsky SC
    J Biochem; 1976 Apr; 79(4):24P-25P. PubMed ID: 931958
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary in vitro immunogenicity of liposomal model membranes in mouse spleen cell cultures.
    Yasuda T; Tadakuma T; Pierce CW; Kinsky SC
    J Immunol; 1979 Oct; 123(4):1535-9. PubMed ID: 314464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine immunogenicity of N-substituted phosphatidylethanolamine derivatives in liposomes: response to the hapten phosphocholine.
    Honegger JL; Isakson PC; Kinsky SC
    J Immunol; 1980 Feb; 124(2):669-75. PubMed ID: 6985935
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of epitope density on the in vitro immunogenicity of hapten-sensitized liposomal model membranes.
    Tadakuma T; Yasuda T; Kinsky SC; Pierce CW
    J Immunol; 1980 May; 124(5):2175-9. PubMed ID: 6154094
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of immunogenic properties of haptenated liposomal model membranes in mice. IV. induction of IgM memory.
    van Houte AJ; Snippe H; Willers JM
    Immunology; 1981 Aug; 43(4):627-34. PubMed ID: 7024108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of immunogenic properties of haptenated liposomal model membranes in mice.
    van Houte AJ; Snippe H; Peulen GT; Willers JM
    Immunology; 1981 Feb; 42(2):233-9. PubMed ID: 6161886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lipid A incorporation on characterization of liposomal model membranes as thymus-independent type 1 or type 2 immunogens.
    Tadakuma T; Yasuda T; Tamauchi H; Saito K; Tsumita T; Kinsky SC
    J Immunol; 1982 Jan; 128(1):206-10. PubMed ID: 6976372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic properties of liposomal model membranes in mice.
    Yasuda T; Dancey GF; Kinsky SC
    J Immunol; 1977 Dec; 119(6):1863-7. PubMed ID: 334973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation and inhibition of anti-hapten responses in guinea pigs immunized with hybrid liposomes.
    Kochibe N; Nicolotti RA; Davie JM; Kinsky SC
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4582-6. PubMed ID: 53840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific suppression of anti-hapten reaginic antibody titers with hapten-coated liposomes.
    Schwenk R; Lee WY; Sehon AH
    J Immunol; 1978 May; 120(5):1612-5. PubMed ID: 659865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of immunogenic properties of haptenated liposomal model membranes in mice. VI. Response in B-cell-defective CBA/N mice.
    Snippe H; van Houte AJ; Lizzio EF; Willers JM; Merchant B
    Immunology; 1982 Mar; 45(3):545-51. PubMed ID: 6174426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of antibody-coated liposomes as a target cell model for antibody-dependent cell-mediated cytotoxicity.
    Geiger B; Schreiber AD
    Clin Exp Immunol; 1979 Jan; 35(1):149-54. PubMed ID: 428143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of liposomal model membranes in mice: dependence on phospholipid composition.
    Yasuda T; Dancey GF; Kinsky SC
    Proc Natl Acad Sci U S A; 1977 Mar; 74(3):1234-6. PubMed ID: 265565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lipid A on the immunologic properties of liposomal model membranes.
    Kinsky SC
    Rev Infect Dis; 1984; 6(4):558-62. PubMed ID: 6206545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.